UNSPSC 51332814: Levomepromazine or methotrimeprazine

This classification denotes a phenothiazine with the molecular formula C19H24N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9G0LAW7ATQ, chemically known as 10h-phenothiazine-10-propanamine, 2-methoxy-n,n,beta-trimethyl-, (r)- but generally known as levomepromazine, which bears US NIH Compound Identifier 3916. European Medicines Agency schedules Levomepromazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08476MIG.

UNSPSC 51332814 Levomepromazine or methotrimeprazine is a Commodity code that does not reflect the actual procurement activity appearing in recent state and local opportunities. The single recent solicitation tagged under this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems — names products entirely outside the scope of the chemical compound specified by the code name. State and local governments do not appear to be using this code for its nominal pharmaceutical category; the mismatch suggests either a tagging error in the source data or that the code sees no genuine activity aligned with its definition.

No recent state and local procurement activity supports substantive business development activity under UNSPSC 51332814. The Seminole County opportunity posted June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistent with the posting year), names naloxone and drug deactivation systems — emergency response pharmaceuticals and medical devices — rather than levomepromazine. Without additional opportunities properly categorized under this code, there is insufficient evidence of market demand or issuing-body engagement to guide pursuit strategy.